Key result
IV fluids resolve recurrent viral rhabdomyolysis in a single patient, reducing CK ~90%.
Why the study?
Rhabdomyolysis can cause life-threatening systemic complications, and recurrent episodes triggered by viral illnesses require clinical attention.
Case Report (n=1)
Highlights a case of recurrent rhabdomyolysis triggered by a viral illness that was successfully managed with conservative IV fluid therapy.
May support conservative IV fluids in select viral rhabdomyolysis cases; hypothesis-generating and requires prospective validation before practice change.
Rhabdomyolysis is a syndrome caused by skeletal muscle disruption that results in the release of muscle proteins into circulation, which can lead to life-threatening systemic complications. These complications include acute kidney injury (AKI), renal failure, compartment syndrome, and disseminated intravascular coagulopathy. Patients commonly present with muscle pain, fatigue, weakness, and dark-colored urine. We present the case of a 37-year-old male who presented to the hospital with pain in the lower limbs and difficulty in mobility for the past two days after returning from Jamaica. He had a mild cold and body aches but denied any sore throat, cough, or shortness of breath (SOB). He tested negative for COVID-19. He had attended his local hospital the previous night, but due to the long waiting time, he presented to the accident and emergency department at our hospital. His physical examination was normal, and his urine was dark in color. All laboratory test results were normal, except for creatinine kinase (CK) levels >100,000 IU/L (reference: 40-320 IU/L) and an alanine transaminase (ALT) level of 376 U/L (reference: 30-130 U/L). Magnetic resonance imaging of both femurs revealed a high signal in multiple muscle compartments bilaterally on a short TI inversion recovery (STIR) sequence. Autoimmune screening results were negative. He had a similar episode last year due to COVID-19 with elevated CK levels. He received conservative treatment with IV fluids and was discharged eight days after hospital admission.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2024) conducted a case report in Recurrent rhabdomyolysis (n=1). Conservative treatment (IV fluids) was evaluated. Conservative treatment with intravenous fluids resolved recurrent viral-induced rhabdomyolysis in a 37-year-old male, reducing creatinine kinase levels from >100,000 U/L to <11,000 U/L in one week.